145 related articles for article (PubMed ID: 38201610)
1. EBP50 Depletion and Nuclear β-Catenin Accumulation Engender Aggressive Behavior of Colorectal Carcinoma through Induction of Tumor Budding.
Itou T; Ishibashi Y; Oguri Y; Hashimura M; Yokoi A; Harada Y; Fukagawa N; Hayashi M; Ono M; Kusano C; Saegusa M
Cancers (Basel); 2023 Dec; 16(1):. PubMed ID: 38201610
[TBL] [Abstract][Full Text] [Related]
2. PTEN overexpression and nuclear β-catenin stabilization promote morular differentiation through induction of epithelial-mesenchymal transition and cancer stem cell-like properties in endometrial carcinoma.
Yokoi A; Minami M; Hashimura M; Oguri Y; Matsumoto T; Hasegawa Y; Nakagawa M; Ishibashi Y; Ito T; Ohhigata K; Harada Y; Fukagawa N; Saegusa M
Cell Commun Signal; 2022 Nov; 20(1):181. PubMed ID: 36411429
[TBL] [Abstract][Full Text] [Related]
3. Aberrant nuclear localization of EBP50 promotes colorectal carcinogenesis in xenotransplanted mice by modulating TCF-1 and β-catenin interactions.
Lin YY; Hsu YH; Huang HY; Shann YJ; Huang CY; Wei SC; Chen CL; Jou TS
J Clin Invest; 2012 May; 122(5):1881-94. PubMed ID: 22466651
[TBL] [Abstract][Full Text] [Related]
4. Interaction between membranous EBP50 and myosin 9 as a favorable prognostic factor in ovarian clear cell carcinoma.
Nakagawa M; Matsumoto T; Yokoi A; Hashimura M; Oguri Y; Konno R; Ishibashi Y; Ito T; Ohhigata K; Harada Y; Fukagawa N; Kodera Y; Saegusa M
Mol Oncol; 2023 Oct; 17(10):2168-2182. PubMed ID: 37539980
[TBL] [Abstract][Full Text] [Related]
5. Tumor suppressor function of ezrin-radixin-moesin-binding phosphoprotein-50 through β-catenin/E-cadherin pathway in human hepatocellular cancer.
Peng XL; Ji MY; Yang ZR; Song J; Dong WG
World J Gastroenterol; 2013 Feb; 19(8):1306-13. PubMed ID: 23483729
[TBL] [Abstract][Full Text] [Related]
6. Loss of EBP50 stimulates EGFR activity to induce EMT phenotypic features in biliary cancer cells.
Clapéron A; Guedj N; Mergey M; Vignjevic D; Desbois-Mouthon C; Boissan M; Saubaméa B; Paradis V; Housset C; Fouassier L
Oncogene; 2012 Mar; 31(11):1376-88. PubMed ID: 21822312
[TBL] [Abstract][Full Text] [Related]
7. EBP50, a beta-catenin-associating protein, enhances Wnt signaling and is over-expressed in hepatocellular carcinoma.
Shibata T; Chuma M; Kokubu A; Sakamoto M; Hirohashi S
Hepatology; 2003 Jul; 38(1):178-86. PubMed ID: 12830000
[TBL] [Abstract][Full Text] [Related]
8. NHERF1/EBP50 is a new marker in colorectal cancer.
Hayashi Y; Molina JR; Hamilton SR; Georgescu MM
Neoplasia; 2010 Dec; 12(12):1013-22. PubMed ID: 21170265
[TBL] [Abstract][Full Text] [Related]
9. EBP50 inhibits pancreatic cancer cell growth and invasion by targeting the β-catenin/E-cadherin pathway.
Ji M; Fan D; Yuan L; Zhang Y; Dong W; Peng X
Exp Ther Med; 2015 Oct; 10(4):1311-1316. PubMed ID: 26622484
[TBL] [Abstract][Full Text] [Related]
10. NHERF1/EBP50 controls morphogenesis of 3D colonic glands by stabilizing PTEN and ezrin-radixin-moesin proteins at the apical membrane.
Georgescu MM; Cote G; Agarwal NK; White CL
Neoplasia; 2014 Apr; 16(4):365-74.e1-2. PubMed ID: 24862762
[TBL] [Abstract][Full Text] [Related]
11. Reduced EBP50 expression levels are correlated with unfavorable clinicopathological features of extrahepatic bile duct carcinoma and promote the proliferation and migration of QBC939 cells.
Feng D; Xiong Y; Peng Z; Ma Q; Tao T; Liu H; Liang J; Wei Z; Zheng J; Wang L; Zhang H
Oncol Lett; 2017 Apr; 13(4):2758-2764. PubMed ID: 28454463
[TBL] [Abstract][Full Text] [Related]
12. Differential β-catenin expression levels are associated with morphological features and prognosis of colorectal cancer.
Gao ZH; Lu C; Wang MX; Han Y; Guo LJ
Oncol Lett; 2014 Nov; 8(5):2069-2076. PubMed ID: 25295092
[TBL] [Abstract][Full Text] [Related]
13. The detection of EBP50 expression using quantum dot immunohistochemistry in pancreatic cancer tissue and down-regulated EBP50 effect on PC-2 cells.
Ji MY; Fan DK; Lv XG; Peng XL; Lei XF; Dong WG
J Mol Histol; 2012 Oct; 43(5):517-26. PubMed ID: 22622406
[TBL] [Abstract][Full Text] [Related]
14. Regulation of merlin by protein phosphatase 1-TIMAP and EBP50 in endothelial cells.
Boratkó A; Péter M; Csortos C
Int J Biochem Cell Biol; 2017 Jan; 82():10-17. PubMed ID: 27871951
[TBL] [Abstract][Full Text] [Related]
15. Expression and clinicopathological significance of oestrogen-responsive ezrin-radixin-moesin-binding phosphoprotein 50 in breast cancer.
Song J; Bai J; Yang W; Gabrielson EW; Chan DW; Zhang Z
Histopathology; 2007 Jul; 51(1):40-53. PubMed ID: 17593079
[TBL] [Abstract][Full Text] [Related]
16. A combination of stromal PD-L1 and tumoral nuclear β-catenin expression as an indicator of colorectal carcinoma progression and resistance to chemoradiotherapy in locally advanced rectal carcinoma.
Takahashi H; Watanabe H; Hashimura M; Matsumoto T; Yokoi A; Nakagawa M; Ishibashi Y; Ito T; Ohhigata K; Saegusa M
J Pathol Clin Res; 2022 Sep; 8(5):458-469. PubMed ID: 35762092
[TBL] [Abstract][Full Text] [Related]
17. Astrocyte elevated gene-1 interacts with β-catenin and increases migration and invasion of colorectal carcinoma.
Zhang F; Yang Q; Meng F; Shi H; Li H; Liang Y; Han A
Mol Carcinog; 2013 Aug; 52(8):603-10. PubMed ID: 22431469
[TBL] [Abstract][Full Text] [Related]
18. Assessment of tumor budding in colorectal carcinoma: correlation with β-catenin nuclear expression.
El-Gendi S; Al-Gendi A
J Egypt Natl Canc Inst; 2011 Mar; 23(1):1-9. PubMed ID: 22099930
[TBL] [Abstract][Full Text] [Related]
19. Identification of Moesin (MSN) as a Potential Therapeutic Target for Colorectal Cancer via the β-Catenin-RUNX2 Axis.
Huang CY; Wei PL; Batzorig U; Makondi PT; Lee CC; Chang YJ
Int J Mol Sci; 2023 Jun; 24(13):. PubMed ID: 37446127
[TBL] [Abstract][Full Text] [Related]
20. Correlation of Wnt antagonist sFPR1, Slug and β-catenin with prognosis and metastasis in colorectal carcinoma.
Wu Q; Zhou L; Yang Y; Qin Y; Ou Y
Int J Clin Exp Pathol; 2018; 11(1):269-280. PubMed ID: 31938110
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
